HCA Holdings, Inc. (NYSE:HCA) saw unusually large options trading on Thursday. Investors purchased 9,836 call options on the company. This represents an increase of approximately 1,863% compared to the average daily volume of 501 call options.
HCA (NYSE:HCA) opened at $84.27 on Tuesday. The firm has a market capitalization of $29,758.12, a price-to-earnings ratio of 12.75, a P/E/G ratio of 1.23 and a beta of 0.56. HCA has a 52-week low of $70.00 and a 52-week high of $91.03. The company has a current ratio of 1.68, a quick ratio of 1.41 and a debt-to-equity ratio of -6.46.
HCA (NYSE:HCA) last posted its quarterly earnings results on Tuesday, October 31st. The company reported $1.21 earnings per share for the quarter, meeting the consensus estimate of $1.21. The firm had revenue of $10.70 billion for the quarter, compared to analyst estimates of $10.70 billion. HCA had a negative return on equity of 47.16% and a net margin of 6.13%. HCA’s quarterly revenue was up 4.1% on a year-over-year basis. During the same period in the previous year, the firm earned $1.45 earnings per share. equities analysts predict that HCA will post 6.56 EPS for the current fiscal year.
Several brokerages have recently weighed in on HCA. Piper Jaffray Companies restated a “buy” rating and issued a $92.00 price objective on shares of HCA in a report on Wednesday, October 4th. Jefferies Group cut their price objective on HCA from $90.00 to $88.00 and set a “buy” rating for the company in a report on Wednesday, November 1st. ValuEngine raised HCA from a “hold” rating to a “buy” rating in a research report on Monday, October 2nd. KeyCorp reaffirmed a “buy” rating and set a $95.00 target price on shares of HCA in a research report on Thursday, September 7th. Finally, Mizuho reaffirmed a “buy” rating on shares of HCA in a research report on Friday, October 20th. Two analysts have rated the stock with a sell rating, six have given a hold rating and eighteen have issued a buy rating to the stock. The company presently has an average rating of “Buy” and an average target price of $90.20.
In other news, SVP Victor L. Campbell sold 8,000 shares of the company’s stock in a transaction on Thursday, November 16th. The stock was sold at an average price of $75.82, for a total value of $606,560.00. Following the completion of the sale, the senior vice president now owns 127,275 shares in the company, valued at $9,649,990.50. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, insider Michael S. Cuffe sold 2,150 shares of the company’s stock in a transaction on Friday, September 15th. The shares were sold at an average price of $79.87, for a total value of $171,720.50. The disclosure for this sale can be found here. Insiders have sold a total of 22,450 shares of company stock valued at $1,737,681 in the last quarter. 2.90% of the stock is currently owned by insiders.
Hedge funds have recently modified their holdings of the business. Northwestern Mutual Wealth Management Co. increased its position in HCA by 14.0% in the 2nd quarter. Northwestern Mutual Wealth Management Co. now owns 1,163 shares of the company’s stock worth $101,000 after purchasing an additional 143 shares during the last quarter. Bronfman E.L. Rothschild L.P. increased its position in HCA by 35.1% in the 2nd quarter. Bronfman E.L. Rothschild L.P. now owns 1,232 shares of the company’s stock worth $107,000 after purchasing an additional 320 shares during the last quarter. Atlantic Trust LLC acquired a new position in HCA in the 2nd quarter worth about $118,000. Lee Financial Co acquired a new position in HCA in the 2nd quarter worth about $125,000. Finally, Acrospire Investment Management LLC increased its position in HCA by 14.3% in the 2nd quarter. Acrospire Investment Management LLC now owns 1,600 shares of the company’s stock worth $140,000 after purchasing an additional 200 shares during the last quarter. 75.35% of the stock is currently owned by institutional investors.
ILLEGAL ACTIVITY NOTICE: This report was posted by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are accessing this report on another site, it was illegally stolen and republished in violation of United States and international trademark and copyright laws. The legal version of this report can be viewed at https://www.dispatchtribunal.com/2017/12/05/hca-sees-unusually-high-options-volume-hca.html.
HCA Healthcare, Inc, formerly HCA Holdings, Inc, is a holding company. The Company, through its subsidiaries, owns and operates hospitals and related healthcare entities. As of December 31, 2016, the Company operated in two geographically organized groups, including the National and American Groups. As of December 31, 2016, the National Group included 84 hospitals, which were located in Alaska, California, Florida, southern Georgia, Idaho, Indiana, northern Kentucky, Nevada, New Hampshire, South Carolina, Utah and Virginia.
Receive News & Ratings for HCA Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Holdings Inc. and related companies with MarketBeat.com's FREE daily email newsletter.